SUBSCRIBE
SUBSCRIBE

Government

Policy
Biopharma Update on the Novel Coronavirus: September 30
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 30, 2020.
September 22, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 28
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 28, 2020.
September 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: September 25
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.
September 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 23
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
September 22, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Policy
FDA Accepts BLA for bluebird and BMS’ Multiple Myeloma CAR-T Treatment
Bristol Myers Squibb and bluebird bio are eying a potential quick approval for a CAR-T treatment for multiple myeloma after the U.S. Food and Drug Administration accepted the Biologics License Application under priority review.
September 22, 2020
 · 
2 min read
 · 
Alex Keown
Policy
NIH Awards Health Tech Companies with Grants to Develop COVID-19 Apps and Solutions
The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the COVID-19 pandemic.
September 22, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Legend Biotech Names Interim CEO Amid Investigation by Chinese Government
Legend’s CEO and Board Chairman, Fangliang “Frank” Zhange, was placed on “residential surveillance” by PRC law enforcement.
September 21, 2020
 · 
3 min read
 · 
Kate Goodwin
Mark Van Scyoc/Shutterstock
Business
New HHS Authority Increases Concerns Over Politicization of Vaccine EUA
Last week, HHS Secretary Alex Azar assumed all final authority in deciding new rules regarding food, medical devices and new medications.
September 21, 2020
 · 
4 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: September 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 21, 2020.
September 21, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: September 18
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 18, 2020.
September 17, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
 · 
10 min read
Press Releases
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
December 22, 2025
 · 
6 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
 · 
2 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
 · 
5 min read
Press Releases
Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint
December 22, 2025
 · 
3 min read
Press Releases
AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
December 22, 2025
 · 
8 min read
Press Releases
Novartis and US government reach agreement on lowering drug prices in the US
December 22, 2025
 · 
5 min read
Press Releases
Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
December 22, 2025
 · 
7 min read
Press Releases
Canada secures African swine fever zoning arrangement with the Philippines
December 17, 2025
 · 
4 min read
Press Releases
Perspectum and InHealth Announce National Diagnostics Partnership to Boost Oxford CDC Capacity and Widen Access to Advanced MRI Across the UK
December 2, 2025
 · 
3 min read
Press Releases
Canada’s $1.5-billion Rare Disease Drug Strategy generating ‘return on investment’ for patients and society but more needs to be done
November 26, 2025
 · 
4 min read
Press Releases
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
November 7, 2025
 · 
15 min read
Press Releases
Rhythm Pharmaceuticals Announces Public Reimbursement for IMCIVREE® (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program
November 5, 2025
 · 
8 min read
Press Releases
Immutep Receives A$4.6 million R&D Tax Incentive from French Government
November 4, 2025
 · 
1 min read
Press Releases
EMD Serono Announces Unprecedented Agreement with U.S. Government to Expand Access to IVF Therapies
October 17, 2025
 · 
6 min read
Press Releases
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
October 13, 2025
 · 
1 min read
Press Releases
Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility
October 2, 2025
 · 
4 min read
Press Releases
VYLOY® (zolbetuximab) in Combination with Chemotherapy for Advanced Gastric or Gastroesophageal Junction Cancer is now funded in both Ontario and Quebec
October 2, 2025
 · 
4 min read
Press Releases
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
September 22, 2025
 · 
3 min read
Press Releases
HHS, CDC Announce First Pharmacist Appointment to ACIP: Hillary F. Blackburn Named Voting Member
September 17, 2025
 · 
3 min read
Load More